| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | BUY | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 5.56▲ | 5.58▼ | 5.57▲ | 5.52▲ | 5.05▲ |
| MA10 | 5.57▲ | 5.57▲ | 5.57▲ | 5.31▲ | 6.22▼ |
| MA20 | 5.59▼ | 5.59▼ | 5.60▼ | 5.02▲ | 7.69▼ |
| MA50 | 5.57▲ | 5.52▲ | 5.36▲ | 6.36▼ | 8.67▼ |
| MA100 | 5.59▼ | 5.35▲ | 5.15▲ | 7.85▼ | 8.84▼ |
| MA200 | 5.61▼ | 5.09▲ | 5.34▲ | 8.81▼ | 8.64▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.004▼ | -0.008▼ | -0.021▼ | 0.194▲ | -0.332▼ |
| RSI | 48.848▼ | 50.653▲ | 53.981▲ | 49.614▼ | 39.117▼ |
| STOCH | 26.667 | 39.819 | 45.810 | 67.571 | 15.112▼ |
| WILL %R | -50.000 | -61.111 | -50.633 | -24.324▲ | -84.456▼ |
| CCI | -2.504 | -40.121 | -35.354 | 119.541▲ | -69.216 |
|
Monday, April 28, 2025 01:44 PM
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, April 28, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that ...
|
|
Thursday, April 24, 2025 05:00 PM
In this article, we are going to take a look at where ORIC Pharmaceuticals Inc. (NASDAQ:ORIC) stands against other biotech penny stocks. Peter Marks’s departure from the FDA has left innovators ...
|
|
Tuesday, April 22, 2025 06:16 AM
ORIC Pharmaceuticals is advancing ORIC-114 for 1st-line EGFR/HER2 exon 20 NSCLC, with comprehensive data expected in the 2nd half of 2025 and a phase 3 trial to start in 2026.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 02/05/25 | 5.735 | 5.735 | 5.53 | 5.57 | 77,538 |
| 01/05/25 | 5.67 | 5.75 | 5.35 | 5.57 | 611,386 |
| 30/04/25 | 5.59 | 5.78 | 5.30 | 5.71 | 724,331 |
| 29/04/25 | 5.04 | 5.885 | 5.03 | 5.65 | 980,713 |
| 28/04/25 | 5.09 | 5.42 | 5.05 | 5.09 | 416,387 |
| 25/04/25 | 5.08 | 5.17 | 4.9105 | 5.10 | 362,897 |
| 24/04/25 | 5.17 | 5.2601 | 5.045 | 5.19 | 352,427 |
| 23/04/25 | 5.36 | 5.66 | 5.125 | 5.17 | 651,635 |
| 22/04/25 | 4.99 | 5.29 | 4.91 | 5.22 | 733,139 |
| 21/04/25 | 4.63 | 5.185 | 4.625 | 4.87 | 501,039 |
|
|
||||
|
|
||||
|
|